The use of all-oral direct-acting antivirals in hepatitis C virus-infected patients with substance use disorders-Reference-Cited by-同舟云学术

The use of all-oral direct-acting antivirals in hepatitis C virus-infected patients with substance use disorders

Published:2021-07 Issue:7 Volume:27 Page:873-881
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Jiang Xinyi¹,Song Hyun Jin¹,Wang Wei¹,Henry Linda¹,Childs-Kean Lindsey M²,Re Vincent Lo³,Park Haesuk¹⁴

Affiliation:

1. University of Florida, College of Pharmacy, Department of Pharmaceutical Outcomes & Policy, FL.

2. University of Florida Pharmacotherapy and Translational Research, College of Pharmacy, Gainesville, FL.

3. University of Pennsylvania, Division of Infectious Diseases, Department of Medicine and Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, Philadelphia, PA.

4. University of Florida, Center for Drug Evaluation and Safety (CoDES), FL.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy;JAMA Network Open;2023-09-26

2. Economic Impact of Universal Hepatitis C Virus Testing for Middle-Aged Adults Who Inject Drugs;American Journal of Preventive Medicine;2023-01

3. The nationwide trends in hospital admissions, deaths, and costs related to hepatitis C stratified by psychiatric disorders and substance use: an analysis of US hospitals between 2016 and 2019;European Journal of Gastroenterology & Hepatology;2022-12-23

4. Disparities in Access to Hepatitis C Treatment Among Arizona Medicaid Beneficiaries With Chronic Hepatitis C;Medical Care;2022-12-01